POLYPEPTID UND VERWENDUNG DAVON

Patent europeic · EP4349871 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4349871
Numer da la dumonda
EP23828948
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-02-2023
Publitgà
10-04-2024
Concedì
01-07-2026
La protecziun finescha il pli tard
22-02-2043
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07K 19/00 (2006.01)
C07K 14/78 (2006.01)
C12N 15/70 (2006.01)
C12N 15/12 (2006.01)
C12N 1/21 (2006.01)
C12P 21/02 (2006.01)
A61L 27/24 (2006.01)
A61L 27/50 (2006.01)
A61L 27/52 (2006.01)
Prioritad
CN 202210761804 29.06.2022
Dumonda PCT
PCT/CN2023/077950 23.02.2023
Publicaziun PCT
WO2024/001242 04.01.2024
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-07-2026

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.07.2026

  2. 01-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.07.2026

Partidas

Possessur

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.

No.18 Jinbo Street Taiyuan Tanghuai Park Shanxi Comprehensive Reform Demonstration Zone, Shanxi 030032, CN

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

YANG, Xia

Taiyuan, Shanxi 030032, CN

HE, Zhenrui

Taiyuan, Shanxi 030032, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.